Diagnostic News and Research

RSS

A new evaluation strategy for assessing stress, allostatic load in primary care

A new evaluation strategy for assessing stress, allostatic load and distress has been found of clinical value in a trial in primary care published in the current issue of Psychotherapy and Psychosomatics.

29 Mar 2019

Study shows link between maternal diet during pregnancy and risk of ADHD symptoms in children

The results of a study led by a team from the Barcelona Institute for Global Health, a center supported by "la Caixa", suggest that the risk of a child developing symptoms of attention deficit hyperactivity disorder (ADHD) may be modulated by the mother's diet during pregnancy.

28 Mar 2019

Garvan researchers develop more accurate method to diagnose cancer subtypes

Developed by researchers at the Garvan Institute of Medical Research, this potential diagnostic method screens a cancer sample for 'fusion genes', estimated to be linked to one in five cancers, and may provide a more accurate snapshot of rearranged DNA found in cancer.

28 Mar 2019

AI technique identifies key patterns from video recording of infant movements

Subtle characteristics in the spontaneous movement of very young babies may reveal clinically important aspects of their neurodevelopment. Visual assessment of typical movement patterns (General movements, GM) by a clinical expert is known to be effective in early identification of e.g. cerebral palsy.

27 Mar 2019

A1c blood test found to be unreliable in diabetes diagnoses

Research has found that many cases of diabetes are missed when the hemoglobin A1c blood test is used solely to diagnose the disease.

26 Mar 2019

Prostate cancer cells 'spit out' a protein that promotes tumor growth

Prostate cancer cells change the behavior of other cells around them, including normal cells, by 'spitting out' a protein from their nucleus, new research has found.

26 Mar 2019

Improved TB Diagnostic Assay for Better Multiplexing from Bruker

In time for the World Tuberculosis (TB) Day 2019 on Sunday, March 24th, Bruker today announced the launch of an important further innovation in the field of tuberculosis diagnostics.

From Bruker BioSpin Group 26 Mar 2019

GPs play pivotal role in ensuring success of new Faster Diagnosis Standard for Cancer

GPs will have a pivotal role in ensuring the success of the new Faster Diagnosis Standard (FDS) for Cancer, new research from the University of Surrey finds.

26 Mar 2019

New technique measures frequency of sounds emitted from biological structures

Did you know that music and diagnostic imaging have something in common? Sounds have a lower or higher pitch depending on the size of the object that creates them.

25 Mar 2019

Special Collection tracks development of new diagnostic tests for tuberculosis

The Cochrane Infectious Diseases Group (link is external) (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis.

25 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Air Force develops genetic test to predict mental performance

A research psychologist at the Air Force Research Laboratory can predict your mental performance from a cheek swab or blood sample.

22 Mar 2019

Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics

Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.

22 Mar 2019

Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit

Q BioMed Inc., a commercial stage biotechnology acceleration development company, announced today that its technology partner Mannin Research Inc. has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression.

From Q BioMed Inc. 21 Mar 2019

Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology

Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute has boosted its radionuclide imaging capabilities with a MILabs VECTor PET/SPECT/CT omni-tomography system.

21 Mar 2019

Itamar Medical launches next-generation WatchPAT system for home sleep apnea testing

Itamar Medical Ltd., a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today announced the launch of WatchPAT 300, the next generation WatchPAT system for home sleep apnea testing.

21 Mar 2019

Researchers develop and validate scale for rating severity of mononucleosis

One to five percent of college students develop infectious mononucleosis each year, and about 10 percent are diagnosed six months later with chronic fatigue syndrome - a complex condition involving severe fatigue coupled with disabling cognitive and musculoskeletal symptoms.

21 Mar 2019